HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
UNII C9R35M8XV6

Substance Identification & Data

This profile provides standardized clinical and technical data for Haemophilus Influenzae Type B Strain 20752 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C9R35M8XV6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C9R35M8XV6

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

C9R35M8XV6

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C87740

National Cancer Institute reference terminology for clinical and research data.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Haemophilus Influenzae Type B Strain 20752 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.